Kevin Watanabe‐Smith

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Discovery and characterization of targetable NTRK point mutations in hematologic neoplasms”.

Discovery and characterization of targetable NTRK point mutations in hematologic neoplasms

Blood(2020)10.1182/blood.2019003691

N/A

0DataRank · unranked

40 citations

Kristin Qian, William H. Bisson, Kevin Watanabe‐Smith, Ariane Huang, Daniel Bottomly +7 more

CDK4/6 inhibition overcomes venetoclax resistance mechanisms with enhanced combination activity in acute myeloid leukemia

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102526

N/A

0DataRank · unranked

1 citations

Jessica Gibbs, Kevin Watanabe‐Smith, Ariel H. Nguyen, Isabel Kenna, Karina Thiel-Klare +12 more

m6a and NuRD complexes regulate monocytic differentiation and resistance to BCL2/BCL2L1 inhibitors in acute myeloid leukemia

Haematologica(2025)10.3324/haematol.2025.287972

N/A

0DataRank · unranked

0 citations

Karen Morris, Quinlan Morrow, Stephen E. Kurtz, Daniel Bottomly, Shannon K. McWeeney +5 more